Lower pretreatment CD4 % and higher HIV-1 RNA levels were associated with reduced efficacy , lower pretreatment CD4 % with shorter time to ART discontinuation because of a protocol-defined toxicity , and no PrNVP with shorter time to first grade 3 adverse event .